H.R. 7482 · 119th Congress · Health
LymeX Authorization Act
What it does
The Congressional Research Service hasn’t published a summary of this bill yet. Summaries usually follow within a few weeks of introduction.
Roll call votes
No recorded roll call votes on this bill. Most bills never get one; many pass by voice vote or unanimous consent, or stay in committee.
What members said about it
-
Last night, the U.S. House of Representatives overwhelmingly approved legislation to provide $150 million over five years in continued funding for Lyme disease research at the U.S. Centers for Disease Control and Prevention (CDC), sending…
“My colleagues will recall that our distinguished colleague, North Carolina Senator Kay Hagan, suffered a tick bite and died in 2019 from encephalitis caused by Powassan virus—the current law and reauthorization is named in her honor.”
-
Rep. Chris Smith (R-NJ), the founder and Co-Chair of the Congressional Lyme and Tick-Borne Disease Caucus, applauded Secretary Robert F. Kennedy Jr.’s announcement today that the U.S. Department of Health and Human Services (HHS) is…
“Under President Trump and Secretary Kennedy’s bold leadership, the HHS is taking important steps towards addressing and mitigating the national public health emergency caused by Lyme disease and other tick-borne illnesses over the past several decades.”
Latest action
Feb 11, 2026 · Referred to the House Committee on Energy and Commerce.